Longitudinal characterization of determinants associated with obesogenic growth patterns in early childhood.

BMI z-score trajectories Childhood obesity group-based trajectory modelling growth trajectories mother–offspring cohort risk factors for childhood obesity

Journal

International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871

Informations de publication

Date de publication:
19 04 2023
Historique:
received: 15 02 2022
accepted: 29 08 2022
medline: 20 4 2023
pubmed: 11 9 2022
entrez: 10 9 2022
Statut: ppublish

Résumé

Longitudinal assessment of the determinants of obesogenic growth trajectories in childhood can suggest appropriate developmental windows for intervention. Latent class growth mixture modelling was used to identify body mass index (BMI) z-score trajectories from birth to age 6 years in 994 children from a prospective mother-offspring cohort (Chinese, Indian and Malay ethnicities) based in Singapore. We evaluated the early-life determinants of the trajectories as well as their associations with cardiometabolic risk markers at age 6 years. Five BMI z-score trajectory patterns were identified, three within the healthy weight range, alongside early-acceleration and late-acceleration obesogenic trajectories. The early-acceleration pattern was characterized by elevated fetal abdominal circumference growth velocity, BMI acceleration immediately after birth and crossing of the obesity threshold by age 2 years. The late-acceleration pattern had normal fetal growth and BMI acceleration after infancy, and approached the obesity threshold by age 6 years. Abdominal fat, liver fat, insulin resistance and odds of pre-hypertension/hypertension were elevated in both groups. Indian ethnicity, high pre-pregnancy BMI, high polygenic risk scores for obesity and shorter breastfeeding duration were common risk factors for both groups. Malay ethnicity and low maternal educational attainment were uniquely associated with early BMI acceleration, whereas nulliparity and obesogenic eating behaviours in early childhood were uniquely associated with late BMI acceleration. BMI acceleration starting immediately after birth or after infancy were both linked to early cardiometabolic alterations. The determinants of these trajectories may be useful for developing early risk stratification and intervention approaches to counteract metabolic adversities linked to childhood obesity.

Sections du résumé

BACKGROUND
Longitudinal assessment of the determinants of obesogenic growth trajectories in childhood can suggest appropriate developmental windows for intervention.
METHODS
Latent class growth mixture modelling was used to identify body mass index (BMI) z-score trajectories from birth to age 6 years in 994 children from a prospective mother-offspring cohort (Chinese, Indian and Malay ethnicities) based in Singapore. We evaluated the early-life determinants of the trajectories as well as their associations with cardiometabolic risk markers at age 6 years.
RESULTS
Five BMI z-score trajectory patterns were identified, three within the healthy weight range, alongside early-acceleration and late-acceleration obesogenic trajectories. The early-acceleration pattern was characterized by elevated fetal abdominal circumference growth velocity, BMI acceleration immediately after birth and crossing of the obesity threshold by age 2 years. The late-acceleration pattern had normal fetal growth and BMI acceleration after infancy, and approached the obesity threshold by age 6 years. Abdominal fat, liver fat, insulin resistance and odds of pre-hypertension/hypertension were elevated in both groups. Indian ethnicity, high pre-pregnancy BMI, high polygenic risk scores for obesity and shorter breastfeeding duration were common risk factors for both groups. Malay ethnicity and low maternal educational attainment were uniquely associated with early BMI acceleration, whereas nulliparity and obesogenic eating behaviours in early childhood were uniquely associated with late BMI acceleration.
CONCLUSION
BMI acceleration starting immediately after birth or after infancy were both linked to early cardiometabolic alterations. The determinants of these trajectories may be useful for developing early risk stratification and intervention approaches to counteract metabolic adversities linked to childhood obesity.

Identifiants

pubmed: 36087338
pii: 6695437
doi: 10.1093/ije/dyac177
pmc: PMC10114026
mid: EMS163493
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

426-439

Subventions

Organisme : NIA NIH HHS
ID : U24 AG047867
Pays : United States
Organisme : NIA NIH HHS
ID : U24AG047867
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/17/31749
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/17/3174
Pays : United Kingdom
Organisme : Department of Health
ID : NF-SI-0515–10042
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215–20004
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Références

Semin Fetal Neonatal Med. 2004 Oct;9(5):419-25
pubmed: 15691778
Diabetes Res Clin Pract. 2014 Mar;103(3):341-63
pubmed: 24847517
J Consult Clin Psychol. 2011 Dec;79(6):759-71
pubmed: 22122291
Am J Clin Nutr. 2015 Nov;102(5):1104-12
pubmed: 26423388
Obesity (Silver Spring). 2007 Mar;15(3):760-71
pubmed: 17372328
Obes Rev. 2013 Nov;14 Suppl 2:106-13
pubmed: 24102951
BMC Med. 2017 Mar 7;15(1):50
pubmed: 28264723
Eur Heart J. 2003 Jan;24(2):151-60
pubmed: 12573272
J Clin Endocrinol Metab. 2012 Jul;97(7):E1099-105
pubmed: 22508709
Am J Clin Nutr. 2020 May 1;111(5):997-1006
pubmed: 32219418
J Public Health (Oxf). 2009 Mar;31(1):131-7
pubmed: 18647751
N Engl J Med. 2011 Apr 7;364(14):1315-25
pubmed: 21470009
Nestle Nutr Inst Workshop Ser. 2019;91:55-67
pubmed: 30865959
Ann Acad Med Singap. 2010 May;39(5):348-52
pubmed: 20535422
Am J Clin Nutr. 2019 Nov 1;110(5):1175-1185
pubmed: 31504088
Clin Obes. 2021 Jun;11(3):e12438
pubmed: 33434953
J Behav Med. 2009 Feb;32(1):1-8
pubmed: 19089605
Int J Epidemiol. 2017 Aug 1;46(4):1329-1331
pubmed: 28938759
Physiol Behav. 2017 Jul 1;176:107-116
pubmed: 28213204
Obesity (Silver Spring). 2020 Dec;28(12):2405-2413
pubmed: 33064936
BMJ. 1993 Dec 11;307(6918):1519-24
pubmed: 8274920
Pediatrics. 2015 Jan;135(1):111-9
pubmed: 25554813
BMJ. 2001 Apr 21;322(7292):949-53
pubmed: 11312225
Birth. 2016 Mar;43(1):68-77
pubmed: 26643773
Obesity (Silver Spring). 2018 Mar;26(3):588-596
pubmed: 29399981
Sci Rep. 2017 Aug 21;7(1):8424
pubmed: 28827610
Obesity (Silver Spring). 2012 Feb;20(2):371-5
pubmed: 21869763
N Engl J Med. 2018 Oct 04;379(14):1303-1312
pubmed: 30281992
N Engl J Med. 2005 Oct 27;353(17):1802-9
pubmed: 16251536
Am J Clin Nutr. 2019 Nov 1;110(5):1049-1050
pubmed: 31504113
Curr Hypertens Rep. 2016 Apr;18(4):28
pubmed: 26951245
Hypertension. 2017 Apr;69(4):691-696
pubmed: 28223474
Obesity (Silver Spring). 2019 Mar;27(3):470-478
pubmed: 30707510
Int J Epidemiol. 2014 Oct;43(5):1401-9
pubmed: 23912809
Nutrients. 2018 May 31;10(6):
pubmed: 29857549
Ann Nutr Metab. 2017;70(3):236-240
pubmed: 28301849
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Am J Clin Nutr. 2016 May;103(5):1311-7
pubmed: 27053381
J Epidemiol Community Health. 2002 Sep;56(9):684-7
pubmed: 12177085
N Engl J Med. 2004 Feb 26;350(9):865-75
pubmed: 14985484

Auteurs

Navin Michael (N)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.

Varsha Gupta (V)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.

Anna Fogel (A)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.

Jonathan Huang (J)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.

Li Chen (L)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.

Suresh Anand Sadananthan (SA)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.

Yi Ying Ong (YY)

Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Izzuddin M Aris (IM)

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, USA.

Wei Wei Pang (WW)

Department of Obstetrics and Gynaecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Wen Lun Yuan (WL)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Université de Paris, CRESS, Inserm, INRAE, Paris, France.

See Ling Loy (SL)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore.
Duke-NUS Medical School, Singapore.

Mya Thway Tint (M)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Obstetrics and Gynaecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Kok Hian Tan (KH)

Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore.
Academic Medicine, Duke-National University of Singapore Graduate Medical School, Singapore.

Jerry Ky Chan (JK)

Duke-NUS Medical School, Singapore.
Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore.

Shiao-Yng Chan (SY)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Obstetrics and Gynaecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Lynette Pei-Chi Shek (LP)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Fabian Yap (F)

Duke-NUS Medical School, Singapore.
Department of Pediatrics, KK Women's and Children's Hospital, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Keith Godfrey (K)

MRC Lifecourse Epidemiology Centre and NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Yap Seng Chong (YS)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Obstetrics and Gynaecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Peter Gluckman (P)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Liggins Institute, University of Auckland, Auckland, New Zealand.

S Sendhil Velan (SS)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Institute of Bioengineering & Bioimaging, Agency for Science Technology and Research, Singapore.

Ciarán G Forde (CG)

Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, Netherlands.

Yung Seng Lee (YS)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Johan G Eriksson (JG)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Obstetrics and Gynaecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.

Neerja Karnani (N)

Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Bioinformatics Institute, Agency for Science Technology and Research, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH